Essential for Value Creation,
Value Capture & Defense
Intellectual Property/Patent Valuations
Patents and intellectual property are the foundation of most Biotech companies. Quantifying the value of these primary intangible assets can be a critical component of value creation. Our independent Intellectual Property/Patent valuation service is an essential component of value optimization.
Credentialing, CPVA (Certified Patent Valuation Analyst), plus our insider’s perspective, is what sets us apart. As principals with first-hand experience in company founding, funding, licensing, and M&A, we possess unparalleled knowledge when it comes to valuations. Our deep understanding of the Biotech industry allows us to provide accurate and reliable valuations for Intellectual Property/Patents.
Acquisitions of Biotech assets and M&A can result in changes that impact enterprise value over time. We provide ongoing valuations to quantify changes in value of intangible assets.
Alpha BioAdvisorsTM is focused on Biotech Value.
Development Program/Product & Enterprise Valuations
Valuations of development Programs, Products and the Enterprise itself are essential to preparing for strategic transactions. As prior Wall Street professionals with extensive Biotech valuation experience plus licensing, M&A and financing transactions, we bring a unique level of expertise to the valuation process.
Whether you are considering a potential merger, acquisition, licensing deal, or investment opportunity, having a discrete, independent, comprehensive and reliable valuation is a baseline requirement. It provides the foundation for informed decision making, risk assessment, and negotiation strategies. Independent valuations of Program/Product assets and Enterprises are of critical importance for establishing a credible, accurate and fair market value.
Alpha BioAdvisorsTM is focused on Biotech Value.
Fairness Opinions
Alpha BioAdvisors™ delivers timely, concise, defensible Fairness Opinions for asset purchases/sales, licensing and enterprise M&A transactions. Our knowledge-base is broad, providing us with the context and precision to conduct in-depth, independent, accurate and timely valuations and fairness opinions. As long-time Biotech experts, Alpha BioAdvisors™ has the bedrock technology, clinical and business knowledge to rapidly analyze pinnacle transactions. The combination of insight gleaned from years of M&A/licensing advisory engagements with major pharma and years of institutional investors/sell-side interactions plus from-the-ground-up company builds – we bring a fortified view of relevancy to these critical valuations. From on-time delivery to value-clarity, Alpha BioAdvisors™ brings a unique skill-set to deliver independent, reliable and credible Fairness Opinions.
Alpha BioAdvisors™ is focused on Biotech value.